MK0974 for Migraine Prophylaxis in Patients With Episodic Migraine (0974-049)(TERMINATED)

This study has been terminated.
(The study was terminated based on a recommendation of the DSMB following the identification of two patients with significant elevations in serum transaminases)
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp. Identifier:
First received: November 24, 2008
Last updated: November 22, 2013
Last verified: November 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2009
  Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)